Determination of Prevalence and Features of HRRm mCRPC (ADAM)

CompletedOBSERVATIONAL
Enrollment

331

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
HRRm mCRPC
Trial Locations (14)

Unknown

Research Site, Barnaul

Research Site, Ufa

Research Site, Chelyabinsk

Research Site, Krasnoyarsk

Research Site, Saint Petersburg

Research Site, Nizhny Novgorod

Research Site, Omsk

Research Site, Vladivostok

Research Site, Yuzhno-Sakhalinsk

Research Site, Yekaterinburg

Research Site, Tyumen

Research Site, Yaroslavl

Research Site, Moscow

Research Site, Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY